메뉴 건너뛰기




Volumn 2, Issue 6, 2012, Pages 241-254

Cannabis, a complex plant: Different compounds and different effects on individuals

Author keywords

cannabidiol; Cannabis; delta 9 tetrahydrocannabinol; endocannabinoids; individual sensitivity to cannabis; tetrahydrocannabivarin

Indexed keywords

CANNABIDIOL; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABIS; CATECHOL METHYLTRANSFERASE; DELTA9(11) TETRAHYDROCANNABINOL; DOPAMINE TRANSPORTER; ENDOCANNABINOID; PROTEIN SERINE THREONINE KINASE;

EID: 84997941865     PISSN: 20451253     EISSN: 20451261     Source Type: Journal    
DOI: 10.1177/2045125312457586     Document Type: Review
Times cited : (384)

References (108)
  • 2
    • 84862829106 scopus 로고    scopus 로고
    • Early cannabis use and schizotypal personality disorder symptoms from adolescence to middle adulthood
    • Anglin D. Corcoran C. Brown A. Chen H. Lighty Q. Brook J. et al. (2012) Early cannabis use and schizotypal personality disorder symptoms from adolescence to middle adulthood. Schizophr Res 137: 45–49.
    • (2012) Schizophr Res , vol.137 , pp. 45-49
    • Anglin, D.1    Corcoran, C.2    Brown, A.3    Chen, H.4    Lighty, Q.5    Brook, J.6
  • 3
    • 0037164390 scopus 로고    scopus 로고
    • Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
    • Arseneault L. Cannon M. Murray R. Poulton R. Caspi A. Moffitt T. (2002) Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325: 1212–1213.
    • (2002) BMJ , vol.325 , pp. 1212-1213
    • Arseneault, L.1    Cannon, M.2    Murray, R.3    Poulton, R.4    Caspi, A.5    Moffitt, T.6
  • 5
    • 35348942818 scopus 로고    scopus 로고
    • Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death
    • Athanasiou A. Clarke A. Turner A. Kumaran N. Vakilpour S. Smith P. et al. (2007) Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. Biochem Biophys Res Commun 364: 131–137.
    • (2007) Biochem Biophys Res Commun , vol.364 , pp. 131-137
    • Athanasiou, A.1    Clarke, A.2    Turner, A.3    Kumaran, N.4    Vakilpour, S.5    Smith, P.6
  • 6
    • 33745218113 scopus 로고    scopus 로고
    • Cannabis-induced psychosis-like experiences are associated with high schizotypy
    • Barkus E. Stirling J. Hopkins R. Lewis S. (2006) Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology 39: 175–178.
    • (2006) Psychopathology , vol.39 , pp. 175-178
    • Barkus, E.1    Stirling, J.2    Hopkins, R.3    Lewis, S.4
  • 7
    • 20844454912 scopus 로고    scopus 로고
    • Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension
    • Batkai S. Pacher P. Osei-Hyiaman D. Radaeva S. Liu J. Harvey-White J. et al. (2004) Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation 110: 1996–2002.
    • (2004) Circulation , vol.110 , pp. 1996-2002
    • Batkai, S.1    Pacher, P.2    Osei-Hyiaman, D.3    Radaeva, S.4    Liu, J.5    Harvey-White, J.6
  • 8
    • 0019604102 scopus 로고
    • Cardiovascular and metabolic considerations in prolonged cannabinoid administration in man
    • Benowitz N. Jones R. (1981) Cardiovascular and metabolic considerations in prolonged cannabinoid administration in man. J Clin Pharmacol 21: 214S–223S.
    • (1981) J Clin Pharmacol , vol.21 , pp. 214S-223S
    • Benowitz, N.1    Jones, R.2
  • 9
    • 84870053882 scopus 로고    scopus 로고
    • Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of delta-9-tetrahydrocannabinol on midbrain and striatal function
    • 31, January, (epub ahead of print)
    • Bhattacharyya S. Atakan Z. Martin-Santos R. Crippa J. Kambeitz J. Prata D. et al. (2012) Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of delta-9-tetrahydrocannabinol on midbrain and striatal function. Mol Psychiatry 31 January (epub ahead of print).
    • (2012) Mol Psychiatry
    • Bhattacharyya, S.1    Atakan, Z.2    Martin-Santos, R.3    Crippa, J.4    Kambeitz, J.5    Prata, D.6
  • 10
    • 69249116618 scopus 로고    scopus 로고
    • Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology
    • Bhattacharyya S. Crippa J. Martin-Santos R. Winton-Brown T. Fusar-Poli P. (2009a) Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology. Curr Pharm Des 15: 2603–2614.
    • (2009) Curr Pharm Des , vol.15 , pp. 2603-2614
    • Bhattacharyya, S.1    Crippa, J.2    Martin-Santos, R.3    Winton-Brown, T.4    Fusar-Poli, P.5
  • 11
    • 64849106877 scopus 로고    scopus 로고
    • Modulation of mediotemporal and ventrostriatal function in humans by delta-9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis
    • Bhattacharyya S. Fusar-Poli P. Borgwardt S. Martin-Santos R. Nosarti C. O’Carroll C. et al. (2009b) Modulation of mediotemporal and ventrostriatal function in humans by delta-9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch Gen Psychiatry 66: 442–451.
    • (2009) Arch Gen Psychiatry , vol.66 , pp. 442-451
    • Bhattacharyya, S.1    Fusar-Poli, P.2    Borgwardt, S.3    Martin-Santos, R.4    Nosarti, C.5    O’Carroll, C.6
  • 13
    • 55349114694 scopus 로고    scopus 로고
    • Neural basis of Δ-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition
    • Borgwardt S. Allen P. Bhattacharyya S. Fusar-Poli P. Crippa J. Seal M. et al. (2008) Neural basis of Δ-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biol Psychiatry 64: 966–973.
    • (2008) Biol Psychiatry , vol.64 , pp. 966-973
    • Borgwardt, S.1    Allen, P.2    Bhattacharyya, S.3    Fusar-Poli, P.4    Crippa, J.5    Seal, M.6
  • 16
    • 84860278770 scopus 로고    scopus 로고
    • Increasing delta-9-tetrahydrocannabinol (Δ-9-THC) content in herbal cannabis over time: systematic review and meta-analysis
    • Cascini F. Aiello C. Di Tanna G. (2011) Increasing delta-9-tetrahydrocannabinol (Δ-9-THC) content in herbal cannabis over time: systematic review and meta-analysis. Curr Drug Abuse Rev 5: 32-40.
    • (2011) Curr Drug Abuse Rev , vol.5 , pp. 32-40
    • Cascini, F.1    Aiello, C.2    Di Tanna, G.3
  • 17
    • 20944446077 scopus 로고    scopus 로고
    • Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction
    • Caspi A. Moffitt T. Cannon M. McClay J. Murray R. Harrington H. et al. (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 57: 1117–1127.
    • (2005) Biol Psychiatry , vol.57 , pp. 1117-1127
    • Caspi, A.1    Moffitt, T.2    Cannon, M.3    McClay, J.4    Murray, R.5    Harrington, H.6
  • 18
    • 33846070616 scopus 로고    scopus 로고
    • The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain
    • Costa B. Trovato A. Comellii F. Giagnoni G. Colleoni M. (2007) The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur J Pharmacol 556: 75–83.
    • (2007) Eur J Pharmacol , vol.556 , pp. 75-83
    • Costa, B.1    Trovato, A.2    Comellii, F.3    Giagnoni, G.4    Colleoni, M.5
  • 19
    • 78650625479 scopus 로고    scopus 로고
    • Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: apreliminary report
    • Crippa J. Derenusson G. Ferrari T. Wichert-Ana L. Duran F. Martin-Santos R. et al. (2011) Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: apreliminary report. J Psychopharmacol 25: 121–130.
    • (2011) J Psychopharmacol , vol.25 , pp. 121-130
    • Crippa, J.1    Derenusson, G.2    Ferrari, T.3    Wichert-Ana, L.4    Duran, F.5    Martin-Santos, R.6
  • 21
    • 0036399623 scopus 로고    scopus 로고
    • Cognitive subjective dose–response effects of acute oral delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users
    • Curran H. Brignell C. Fletcher S. Middleton P. Henry J. (2002) Cognitive subjective dose–response effects of acute oral delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology 164: 61–70.
    • (2002) Psychopharmacology , vol.164 , pp. 61-70
    • Curran, H.1    Brignell, C.2    Fletcher, S.3    Middleton, P.4    Henry, J.5
  • 22
    • 80051793829 scopus 로고    scopus 로고
    • A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers
    • Dakwar E. Nunes E. Bisaga A. Carpenter K. Mariani J. Sullivan M. et al. (2011) A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers. Am J Addict 20: 441–446.
    • (2011) Am J Addict , vol.20 , pp. 441-446
    • Dakwar, E.1    Nunes, E.2    Bisaga, A.3    Carpenter, K.4    Mariani, J.5    Sullivan, M.6
  • 23
    • 77950683424 scopus 로고    scopus 로고
    • Outcomes of occasional cannabis use in adolescence: 10-year follow-up study in Victoria, Australia
    • Degenhardt L. Coffey C. Carlin J. Swift W. Moore E. Patton G. (2010) Outcomes of occasional cannabis use in adolescence: 10-year follow-up study in Victoria, Australia. Br J Psychiatry 196: 290–295.
    • (2010) Br J Psychiatry , vol.196 , pp. 290-295
    • Degenhardt, L.1    Coffey, C.2    Carlin, J.3    Swift, W.4    Moore, E.5    Patton, G.6
  • 25
    • 0024263922 scopus 로고
    • Determination and characterization of a cannabinoid receptor in rat brain
    • Devane W. Dysarz F. Johnson M. Melvin L. Howlett A. (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34: 605–613.
    • (1988) Mol Pharmacol , vol.34 , pp. 605-613
    • Devane, W.1    Dysarz, F.2    Johnson, M.3    Melvin, L.4    Howlett, A.5
  • 26
    • 0027078685 scopus 로고
    • Isolation and structure of a brain constituent that binds to the cannabinoid receptor
    • Devane W. Hanus L. Breuer A. Pertwee R. Stevenson L. Griffin G. et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946–1949.
    • (1992) Science , vol.258 , pp. 1946-1949
    • Devane, W.1    Hanus, L.2    Breuer, A.3    Pertwee, R.4    Stevenson, L.5    Griffin, G.6
  • 27
    • 0022509199 scopus 로고
    • Cannabinoid pharmacology
    • Dewey W. (1986) Cannabinoid pharmacology. Pharmacol Rev 38: 151–178.
    • (1986) Pharmacol Rev , vol.38 , pp. 151-178
    • Dewey, W.1
  • 29
    • 79953906205 scopus 로고    scopus 로고
    • Gut feelings about the endocannabinoid system
    • Di Marzo V. Piscitelli F. (2011) Gut feelings about the endocannabinoid system. Neurogastroenterol Motil 23: 391–398.
    • (2011) Neurogastroenterol Motil , vol.23 , pp. 391-398
    • Di Marzo, V.1    Piscitelli, F.2
  • 30
    • 79955632246 scopus 로고    scopus 로고
    • Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes
    • Di Marzo V. Piscitelli F. Mechoulam R. (2011) Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. Handb Exp Pharmacol 203: 75–104.
    • (2011) Handb Exp Pharmacol , vol.203 , pp. 75-104
    • Di Marzo, V.1    Piscitelli, F.2    Mechoulam, R.3
  • 31
    • 3242789385 scopus 로고    scopus 로고
    • The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis
    • D’Souza D. Perry E. MacDougall L. Ammerman Y. Cooper T. Wu Y. et al. (2004) The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29: 1558–1572.
    • (2004) Neuropsychopharmacology , vol.29 , pp. 1558-1572
    • D’Souza, D.1    Perry, E.2    MacDougall, L.3    Ammerman, Y.4    Cooper, T.5    Wu, Y.6
  • 34
    • 84858287557 scopus 로고    scopus 로고
    • Are early-onset cannabis smokers at an increased risk of depression spells?
    • Fairman B. Anthony J. (2012) Are early-onset cannabis smokers at an increased risk of depression spells? J Affect Disord 138: 54–62.
    • (2012) J Affect Disord , vol.138 , pp. 54-62
    • Fairman, B.1    Anthony, J.2
  • 35
    • 58149096475 scopus 로고    scopus 로고
    • Looking for the role of cannabinoid receptor heteromers in striatal function
    • Ferré S. Goldberg S. Lluis C. Franco R. (2009) Looking for the role of cannabinoid receptor heteromers in striatal function. Neuropharmacology 56(Suppl. 1): 226–234.
    • (2009) Neuropharmacology , vol.56 , pp. 226-234
    • Ferré, S.1    Goldberg, S.2    Lluis, C.3    Franco, R.4
  • 36
    • 58149520644 scopus 로고    scopus 로고
    • Distinct effects of delta-9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing
    • Fusar-Poli P. Crippa J. Bhattacharyya S. Borgwardt S. Allen P. Martin-Santos R. et al. (2009) Distinct effects of delta-9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry 66: 95–105.
    • (2009) Arch Gen Psychiatry , vol.66 , pp. 95-105
    • Fusar-Poli, P.1    Crippa, J.2    Bhattacharyya, S.3    Borgwardt, S.4    Allen, P.5    Martin-Santos, R.6
  • 37
    • 33947489961 scopus 로고
    • Isolation, structure and partial synthesis of an active constituent of hashish
    • Gaoni Y. Mechoulam R. (1964) Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 86: 1646–1647.
    • (1964) J Am Chem Soc , vol.86 , pp. 1646-1647
    • Gaoni, Y.1    Mechoulam, R.2
  • 38
    • 33646837088 scopus 로고    scopus 로고
    • Methods for clinical research involving cannabis administration
    • Gorelick D. Heishman S. (2006) Methods for clinical research involving cannabis administration. Methods Mol Med 123: 235–253.
    • (2006) Methods Mol Med , vol.123 , pp. 235-253
    • Gorelick, D.1    Heishman, S.2
  • 39
    • 0344685410 scopus 로고    scopus 로고
    • Being stoned: a review of self-reported cannabis effects
    • Green B. Kavanagh D. Young R. (2003) Being stoned: a review of self-reported cannabis effects. Drug Alcohol Rev 22: 453–460.
    • (2003) Drug Alcohol Rev , vol.22 , pp. 453-460
    • Green, B.1    Kavanagh, D.2    Young, R.3
  • 40
    • 0031743712 scopus 로고    scopus 로고
    • Marijuana smoking vs cannabinoids for glaucoma therapy
    • Green K. (1998) Marijuana smoking vs cannabinoids for glaucoma therapy. Arch Ophthalmol 116: 1433–1437.
    • (1998) Arch Ophthalmol , vol.116 , pp. 1433-1437
    • Green, K.1
  • 41
    • 34249999724 scopus 로고    scopus 로고
    • Prevalence and correlates of cannabis use in developed and developing countries
    • Hall W. Degenhardt L. (2007) Prevalence and correlates of cannabis use in developed and developing countries. Curr Opin Psychiatry 20: 393–397.
    • (2007) Curr Opin Psychiatry , vol.20 , pp. 393-397
    • Hall, W.1    Degenhardt, L.2
  • 42
    • 37349071370 scopus 로고    scopus 로고
    • Cannabidiol potentiates pharmacological effects of delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism
    • Hayakawa K. Mishima K. Hazekawa M. Sano K. Orito K. et al. (2008) Cannabidiol potentiates pharmacological effects of delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism. Brain Res 1888: 157–164.
    • (2008) Brain Res , vol.1888 , pp. 157-164
    • Hayakawa, K.1    Mishima, K.2    Hazekawa, M.3    Sano, K.4    Orito, K.5
  • 43
    • 11244260452 scopus 로고    scopus 로고
    • Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people
    • Henquet C. Krabbendam L. Spauwen J. Kaplan C. Lieb R. Wittchen H. et al. (2004) Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 330: 11–14.
    • (2004) BMJ , vol.330 , pp. 11-14
    • Henquet, C.1    Krabbendam, L.2    Spauwen, J.3    Kaplan, C.4    Lieb, R.5    Wittchen, H.6
  • 44
    • 11244260452 scopus 로고    scopus 로고
    • Prospective cohort study of cannabis use, predisposition for psychosis and psychotic symptoms in young people
    • Henquet C. Krabbendam L. Spauwen J. Kaplan C. Lieb R. Wittchen H. et al. (2005) Prospective cohort study of cannabis use, predisposition for psychosis and psychotic symptoms in young people. BMJ 330: 11.
    • (2005) BMJ , vol.330 , pp. 11
    • Henquet, C.1    Krabbendam, L.2    Spauwen, J.3    Kaplan, C.4    Lieb, R.5    Wittchen, H.6
  • 45
    • 18444376760 scopus 로고    scopus 로고
    • International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
    • Howlett A. Barth F. Bonner T. Cabral G. Casellas P. Devane W. et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54: 161–202.
    • (2002) Pharmacol Rev , vol.54 , pp. 161-202
    • Howlett, A.1    Barth, F.2    Bonner, T.3    Cabral, G.4    Casellas, P.5    Devane, W.6
  • 46
    • 0035142746 scopus 로고    scopus 로고
    • In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor
    • Iwamura H. Suzuki H. Ueda Y. Kaya T. Inaba T. (2001) In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor. J Pharmacol Exp Ther 296: 420–425.
    • (2001) J Pharmacol Exp Ther , vol.296 , pp. 420-425
    • Iwamura, H.1    Suzuki, H.2    Ueda, Y.3    Kaya, T.4    Inaba, T.5
  • 47
    • 4444234226 scopus 로고    scopus 로고
    • Cannabinoids and intestinal motility: welcome to CB2 receptors
    • Izzo A. (2004) Cannabinoids and intestinal motility: welcome to CB2 receptors. Br J Pharmacol 142: 1201–1202.
    • (2004) Br J Pharmacol , vol.142 , pp. 1201-1202
    • Izzo, A.1
  • 48
    • 84998049299 scopus 로고    scopus 로고
    • Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells
    • 9, December, (epub ahead of print)
    • Juknat A. Rimmerman N. Levy R. Vogel Z. Kozela E. (2011) Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells. Neurochem Int 9 December (epub ahead of print).
    • (2011) Neurochem Int
    • Juknat, A.1    Rimmerman, N.2    Levy, R.3    Vogel, Z.4    Kozela, E.5
  • 49
    • 0015537176 scopus 로고
    • Comparative studies in man and in laboratory animals on 8- and 9-trans-tetrahydrocannabinol
    • Karniol I. Carlini E. (1973) Comparative studies in man and in laboratory animals on 8- and 9-trans-tetrahydrocannabinol. Pharmacology 9: 115–126.
    • (1973) Pharmacology , vol.9 , pp. 115-126
    • Karniol, I.1    Carlini, E.2
  • 50
  • 51
    • 0032857273 scopus 로고    scopus 로고
    • Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta
    • Kenney S. Kekuda R. Prasad P. Leibach F. Devoe L. Ganapathy V. (1999) Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta. Am J Obstet Gynecol 181: 491–497.
    • (1999) Am J Obstet Gynecol , vol.181 , pp. 491-497
    • Kenney, S.1    Kekuda, R.2    Prasad, P.3    Leibach, F.4    Devoe, L.5    Ganapathy, V.6
  • 52
    • 72549092256 scopus 로고    scopus 로고
    • Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review
    • Lakhan S. Rowland M. (2009) Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review. BMC Neurol 9: 59.
    • (2009) BMC Neurol , vol.9 , pp. 59
    • Lakhan, S.1    Rowland, M.2
  • 53
    • 0002649325 scopus 로고
    • An archaeological and historical account of cannabis in China
    • Li H. (1973) An archaeological and historical account of cannabis in China. Economic Botany 28: 437–448.
    • (1973) Economic Botany , vol.28 , pp. 437-448
    • Li, H.1
  • 54
    • 33646814424 scopus 로고    scopus 로고
    • Cannabinoid receptors and endocannabinoids: evidence for new players
    • Mackie K. Stella N. (2006) Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS J 8: E298–E306.
    • (2006) AAPS J , vol.8 , pp. E298-E306
    • Mackie, K.1    Stella, N.2
  • 55
    • 40849137554 scopus 로고    scopus 로고
    • Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis
    • Marcellino D. Carriba P. Filip M. Borgkvist A. Frankowska M. Bellido I. et al. (2008) Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis. Neuropharmacology 54: 815–823.
    • (2008) Neuropharmacology , vol.54 , pp. 815-823
    • Marcellino, D.1    Carriba, P.2    Filip, M.3    Borgkvist, A.4    Frankowska, M.5    Bellido, I.6
  • 56
    • 0025325535 scopus 로고
    • Structure of a cannabinoid receptor and functional expression of the cloned cDNA
    • Matsuda L. Lolait S. Brownstein M. Young A. Bonner T. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561–564.
    • (1990) Nature , vol.346 , pp. 561-564
    • Matsuda, L.1    Lolait, S.2    Brownstein, M.3    Young, A.4    Bonner, T.5
  • 57
    • 0028903746 scopus 로고
    • Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis
    • McGuire P. Jones P. Harvey I. Williams M. McGuffin P. Murray R. (1995) Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis. Schizophr Res 15: 277–281.
    • (1995) Schizophr Res , vol.15 , pp. 277-281
    • McGuire, P.1    Jones, P.2    Harvey, I.3    Williams, M.4    McGuffin, P.5    Murray, R.6
  • 58
    • 0029012014 scopus 로고
    • Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
    • Mechoulam R. Ben-Shabat S. Hanuš L. Ligumsky M. Kaminski N. Schatz A. et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50: 83–90.
    • (1995) Biochem Pharmacol , vol.50 , pp. 83-90
    • Mechoulam, R.1    Ben-Shabat, S.2    Hanuš, L.3    Ligumsky, M.4    Kaminski, N.5    Schatz, A.6
  • 59
    • 0033660254 scopus 로고    scopus 로고
    • A historical overview of chemical research on cannabinoids
    • Mechoulam R. Hanus L. (2000) A historical overview of chemical research on cannabinoids. Chems Phys Lipids 108: 1–13.
    • (2000) Chems Phys Lipids , vol.108 , pp. 1-13
    • Mechoulam, R.1    Hanus, L.2
  • 60
    • 0013768939 scopus 로고
    • Hashish. I. The structure of cannabidiol
    • Mechoulam R. Shvo Y. (1963) Hashish. I. The structure of cannabidiol. Tetrahedron 19: 2073–2078.
    • (1963) Tetrahedron , vol.19 , pp. 2073-2078
    • Mechoulam, R.1    Shvo, Y.2
  • 61
    • 0037111841 scopus 로고    scopus 로고
    • Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signalling
    • Molina-Holgado E. Vela J. Arévalo-Martin A. Almazán G. Molina-Holgado F. Borrell J. et al. (2002) Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signalling. J Neurosci 22: 9742–9753.
    • (2002) J Neurosci , vol.22 , pp. 9742-9753
    • Molina-Holgado, E.1    Vela, J.2    Arévalo-Martin, A.3    Almazán, G.4    Molina-Holgado, F.5    Borrell, J.6
  • 62
    • 34447619511 scopus 로고    scopus 로고
    • Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
    • Moore T. Zammit S. Lingford-Hughes A. Barnes T. Jones P. Burke M. et al. (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370: 319–328.
    • (2007) Lancet , vol.370 , pp. 319-328
    • Moore, T.1    Zammit, S.2    Lingford-Hughes, A.3    Barnes, T.4    Jones, P.5    Burke, M.6
  • 63
    • 17444393586 scopus 로고    scopus 로고
    • Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice
    • Moreira F. Guimaraes F. (2005) Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice. Eur J Pharmacol 512: 199–205.
    • (2005) Eur J Pharmacol , vol.512 , pp. 199-205
    • Moreira, F.1    Guimaraes, F.2
  • 64
    • 84867326573 scopus 로고    scopus 로고
    • Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
    • Morgan C. Gardener C. Schafer G. Swan S. Demarchi C. Freeman T. et al. (2011) Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. Psychol Med 29: 1–10.
    • (2011) Psychol Med , vol.29 , pp. 1-10
    • Morgan, C.1    Gardener, C.2    Schafer, G.3    Swan, S.4    Demarchi, C.5    Freeman, T.6
  • 65
    • 77957687873 scopus 로고    scopus 로고
    • Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
    • Morgan C. Schafer G. Freeman T. Curran H. (2010) Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study. Br J Psychiatry 197: 285–290.
    • (2010) Br J Psychiatry , vol.197 , pp. 285-290
    • Morgan, C.1    Schafer, G.2    Freeman, T.3    Curran, H.4
  • 66
    • 70449629796 scopus 로고    scopus 로고
    • The acute effects of synthetic intravenous delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning
    • Morrison P. Zois V. McKeown D. Lee T. Holt D. Powell J. et al. (2009) The acute effects of synthetic intravenous delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med 39: 1607–1616.
    • (2009) Psychol Med , vol.39 , pp. 1607-1616
    • Morrison, P.1    Zois, V.2    McKeown, D.3    Lee, T.4    Holt, D.5    Powell, J.6
  • 67
    • 0027515373 scopus 로고
    • Molecular characterization of a peripheral receptor for cannabinoids
    • Munro S. Thomas K. Abu-Shaar M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61–65.
    • (1993) Nature , vol.365 , pp. 61-65
    • Munro, S.1    Thomas, K.2    Abu-Shaar, M.3
  • 68
    • 55549147195 scopus 로고    scopus 로고
    • Detection of heteromers formed by cannabinoid CB2, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer
    • Navarro G. Carriba P. Gandia J. Ciruela F. Casadó V. Cortés A. et al. (2008) Detection of heteromers formed by cannabinoid CB2, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer. ScientificWorldJournal 8: 1088–1097.
    • (2008) ScientificWorldJournal , vol.8 , pp. 1088-1097
    • Navarro, G.1    Carriba, P.2    Gandia, J.3    Ciruela, F.4    Casadó, V.5    Cortés, A.6
  • 69
    • 2442640362 scopus 로고    scopus 로고
    • Effect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults
    • Nicholson A. Turner C. Stone B. Robson P. (2004) Effect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol 24: 305–313.
    • (2004) J Clin Psychopharmacol , vol.24 , pp. 305-313
    • Nicholson, A.1    Turner, C.2    Stone, B.3    Robson, P.4
  • 70
    • 33751204139 scopus 로고    scopus 로고
    • Independent versus substance-induced major depressive disorder in substance-dependent patients: observational study of course during follow-up
    • Nunes E. Liu X. Samet S. Matseoane K. Hasin D. (2006) Independent versus substance-induced major depressive disorder in substance-dependent patients: observational study of course during follow-up. J Clin Psychiatry 67: 1561–1567.
    • (2006) J Clin Psychiatry , vol.67 , pp. 1561-1567
    • Nunes, E.1    Liu, X.2    Samet, S.3    Matseoane, K.4    Hasin, D.5
  • 71
    • 32444440208 scopus 로고    scopus 로고
    • The emerging role of the endocannabinoid system in endocrine regulation and energy balance
    • Pagotto U. Marsicano G. Cota D. Lutz B. Pasquali R. (2006) The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 27: 73–100.
    • (2006) Endocr Rev , vol.27 , pp. 73-100
    • Pagotto, U.1    Marsicano, G.2    Cota, D.3    Lutz, B.4    Pasquali, R.5
  • 72
    • 84856456258 scopus 로고    scopus 로고
    • Psychopharmacology of the endocannabinoids: far beyond anandamide
    • Pamplona F. Takahashi R. (2012) Psychopharmacology of the endocannabinoids: far beyond anandamide. J Psychopharmacol 26: 7–22.
    • (2012) J Psychopharmacol , vol.26 , pp. 7-22
    • Pamplona, F.1    Takahashi, R.2
  • 73
    • 79960304851 scopus 로고    scopus 로고
    • Regulation of nausea and vomiting by cannabinoids
    • Parker L. Rock E. Limebeer C. (2011) Regulation of nausea and vomiting by cannabinoids. Br J Pharmacol 163: 1411–1422.
    • (2011) Br J Pharmacol , vol.163 , pp. 1411-1422
    • Parker, L.1    Rock, E.2    Limebeer, C.3
  • 74
    • 0030611978 scopus 로고    scopus 로고
    • Pharmacology of cannabinoid CB1 and CB2 receptors
    • Pertwee R. (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74: 129– 180.
    • (1997) Pharmacol Ther , vol.74 , pp. 129-180
    • Pertwee, R.1
  • 75
    • 33645502759 scopus 로고    scopus 로고
    • The pharmacology of cannabinoid receptors and their ligands: an overview
    • Pertwee R. (2006) The pharmacology of cannabinoid receptors and their ligands: an overview. Int J Obes (Lond) 30: S13–S18.
    • (2006) Int J Obes (Lond) , vol.30 , pp. S13-S18
    • Pertwee, R.1
  • 76
    • 38349158960 scopus 로고    scopus 로고
    • The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin
    • Pertwee R. (2008) The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br J Pharmacol 153: 199–215.
    • (2008) Br J Pharmacol , vol.153 , pp. 199-215
    • Pertwee, R.1
  • 77
    • 65449146377 scopus 로고    scopus 로고
    • Emerging strategies for exploiting cannabinoid receptor agonists as medicines
    • Pertwee R. (2009) Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol 156: 397–411.
    • (2009) Br J Pharmacol , vol.156 , pp. 397-411
    • Pertwee, R.1
  • 78
    • 77950653576 scopus 로고    scopus 로고
    • Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists
    • Pertwee R. (2010) Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr Med Chem 17: 1360–1381.
    • (2010) Curr Med Chem , vol.17 , pp. 1360-1381
    • Pertwee, R.1
  • 79
    • 78650120798 scopus 로고    scopus 로고
    • International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2
    • Pertwee R. Howlett A. Abood M. Alexander S. Di Marzo V. Elphick M. (2010) International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 62: 588–631.
    • (2010) Pharmacol Rev , vol.62 , pp. 588-631
    • Pertwee, R.1    Howlett, A.2    Abood, M.3    Alexander, S.4    Di Marzo, V.5    Elphick, M.6
  • 81
    • 33144488036 scopus 로고    scopus 로고
    • Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens
    • Pickel V. Chan J. Kearn C. Mackie K. (2006) Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. J Comp Neurol 495: 299–313.
    • (2006) J Comp Neurol , vol.495 , pp. 299-313
    • Pickel, V.1    Chan, J.2    Kearn, C.3    Mackie, K.4
  • 82
    • 39049124647 scopus 로고    scopus 로고
    • Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology
    • Potter D. Clark P. Brown M. (2008) Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology. J Forensic Sci 53: 90–94.
    • (2008) J Forensic Sci , vol.53 , pp. 90-94
    • Potter, D.1    Clark, P.2    Brown, M.3
  • 83
    • 33744916587 scopus 로고    scopus 로고
    • Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects
    • Raduner S. Majewska A. Chen J. Xie X. Hamon J. Faller B. et al. (2006) Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects. J Biol Chem 281: 14192–14206.
    • (2006) J Biol Chem , vol.281 , pp. 14192-14206
    • Raduner, S.1    Majewska, A.2    Chen, J.3    Xie, X.4    Hamon, J.5    Faller, B.6
  • 84
    • 84860895849 scopus 로고    scopus 로고
    • Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1
    • Ramer R. Bublitz K. Freimuth N. Merkord J. Rohde H. Haustein M. et al. (2012) Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1. FASEB J 26: 1535-1548.
    • (2012) FASEB J , vol.26 , pp. 1535-1548
    • Ramer, R.1    Bublitz, K.2    Freimuth, N.3    Merkord, J.4    Rohde, H.5    Haustein, M.6
  • 85
    • 0030756533 scopus 로고    scopus 로고
    • Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase
    • Rhee M. Vogel Z. Barg J. Bayewitch M. Levy R. Hanus L. et al. (1997) Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase. J Med Chem 40: 3228–3233.
    • (1997) J Med Chem , vol.40 , pp. 3228-3233
    • Rhee, M.1    Vogel, Z.2    Barg, J.3    Bayewitch, M.4    Levy, R.5    Hanus, L.6
  • 87
    • 28844489930 scopus 로고    scopus 로고
    • A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol andcannabidiol
    • Russo E. Guy G. (2006) A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol andcannabidiol. Med Hypotheses 66: 234–246.
    • (2006) Med Hypotheses , vol.66 , pp. 234-246
    • Russo, E.1    Guy, G.2
  • 88
    • 34548483175 scopus 로고    scopus 로고
    • Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine
    • Russo E. Guy G. Robson P. (2007) Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Chem Biodivers 4: 1729–1743.
    • (2007) Chem Biodivers , vol.4 , pp. 1729-1743
    • Russo, E.1    Guy, G.2    Robson, P.3
  • 89
    • 0030425575 scopus 로고    scopus 로고
    • Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands
    • Ther
    • Showalter V. Compton D. Martin B. Abood M. (1996) Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 278: 989–999.
    • (1996) J Pharmacol Exp , vol.278 , pp. 989-999
    • Showalter, V.1    Compton, D.2    Martin, B.3    Abood, M.4
  • 91
    • 51349095496 scopus 로고    scopus 로고
    • Cannabis-induced psychotic-like experiences are predicted by high schizotypy. Confirmation of preliminary results in a large cohort
    • Stirling J. Barkus E. Nabosi L. Irshad S. Roemer G. Schreudergoidheijt B. et al. (2008) Cannabis-induced psychotic-like experiences are predicted by high schizotypy. Confirmation of preliminary results in a large cohort. Psychopathology 41: 371–378.
    • (2008) Psychopathology , vol.41 , pp. 371-378
    • Stirling, J.1    Barkus, E.2    Nabosi, L.3    Irshad, S.4    Roemer, G.5    Schreudergoidheijt, B.6
  • 92
    • 84997908352 scopus 로고    scopus 로고
    • Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?
    • Stone J. (2011) Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia? Ther Adv Psychopharmacol 1: 5–18.
    • (2011) Ther Adv Psychopharmacol , vol.1 , pp. 5-18
    • Stone, J.1
  • 94
    • 68749088245 scopus 로고    scopus 로고
    • Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand
    • Terry G. Liow J. Zoghbi S. Hirvonen J. Farris A. Lerner A. (2009) Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand. Neuroimage 48: 362–370.
    • (2009) Neuroimage , vol.48 , pp. 362-370
    • Terry, G.1    Liow, J.2    Zoghbi, S.3    Hirvonen, J.4    Farris, A.5    Lerner, A.6
  • 95
    • 0030561432 scopus 로고    scopus 로고
    • A community survey of adverse effects of cannabis use
    • Thomas H. (1996) A community survey of adverse effects of cannabis use, Drug Alcohol Depend 42: 201–207.
    • (1996) Drug Alcohol Depend , vol.42 , pp. 201-207
    • Thomas, H.1
  • 97
    • 0031929438 scopus 로고    scopus 로고
    • Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
    • Tsou K. Brown S. Sanudo-Pena M. Mackie K. Walker J. (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83: 393–411.
    • (1998) Neuroscience , vol.83 , pp. 393-411
    • Tsou, K.1    Brown, S.2    Sanudo-Pena, M.3    Mackie, K.4    Walker, J.5
  • 98
    • 0037103169 scopus 로고    scopus 로고
    • Cannabis use and psychosis: a longitudinal population-based study
    • van Os J. Bak M. Bijl R. De Graaf R. Verdoux H. (2002) Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 156: 319–327.
    • (2002) Am J Epidemiol , vol.156 , pp. 319-327
    • van Os, J.1    Bak, M.2    Bijl, R.3    De Graaf, R.4    Verdoux, H.5
  • 99
    • 68949180394 scopus 로고    scopus 로고
    • Schizophrenia
    • van Os J. Kapur S. (2009) Schizophrenia. Lancet 374: 635–645.
    • (2009) Lancet , vol.374 , pp. 635-645
    • van Os, J.1    Kapur, S.2
  • 100
    • 84865982317 scopus 로고    scopus 로고
    • CB1 cannabinoid receptor expression in the striatum: association with corticostriatal circuits and developmental regulation
    • van Waes V. Beverley J. Siman H. Tseng K. Steiner H. (2012) CB1 cannabinoid receptor expression in the striatum: association with corticostriatal circuits and developmental regulation. Front Pharmacol 3: 21.
    • (2012) Front Pharmacol , vol.3 , pp. 21
    • van Waes, V.1    Beverley, J.2    Siman, H.3    Tseng, K.4    Steiner, H.5
  • 101
    • 79951472497 scopus 로고    scopus 로고
    • Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up
    • van Winkel R., Genetic Risk and Outcome of Psychosis (GROUP) Investigators (2011) Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up. Arch Gen Psychiatry 68: 148–157.
    • (2011) Arch Gen Psychiatry , vol.68 , pp. 148-157
    • van Winkel, R.1
  • 102
    • 0035964576 scopus 로고    scopus 로고
    • Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects
    • Wallace M. Wiley J. Martin B. DeLorenzo R. (2001) Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects. Eur J Pharmacol 428: 51–57.
    • (2001) Eur J Pharmacol , vol.428 , pp. 51-57
    • Wallace, M.1    Wiley, J.2    Martin, B.3    DeLorenzo, R.4
  • 104
    • 0003083642 scopus 로고
    • Cannabinol, part I
    • Wood T. (1899) Cannabinol, part I. J Chem Soc 75: 20–36.
    • (1899) J Chem Soc , vol.75 , pp. 20-36
    • Wood, T.1
  • 105
    • 0037164374 scopus 로고    scopus 로고
    • Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study
    • Zammit S. Allebeck P. Andreasson S. Lundberg I. Lewis G. (2002) Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 325: 1199–1201.
    • (2002) BMJ , vol.325 , pp. 1199-1201
    • Zammit, S.1    Allebeck, P.2    Andreasson, S.3    Lundberg, I.4    Lewis, G.5
  • 106
    • 35948986314 scopus 로고    scopus 로고
    • Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use
    • Zammit S. Spurlock G. Williams H. Norton N. Williams N. O’Donovan M. et al. (2007) Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use Br J Psychiatry 191: 402–407.
    • (2007) Br J Psychiatry , vol.191 , pp. 402-407
    • Zammit, S.1    Spurlock, G.2    Williams, H.3    Norton, N.4    Williams, N.5    O’Donovan, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.